Clinical Trial Update: iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD) [Phase 3]

View source ↗

Summary

Phase 3 trial TRIAD evaluating an investigational SGLT2 inhibitor in combination with an investigational DPP-4 inhibitor for type 2 diabetes mellitus in metform…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• iDPP-4 inhibitor
• iSGLT2 inhibitor

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: WITHDRAWN